Education
and Training:
Education:
1982
B.A., Accelerated Candidate
University of Chicago
Chicago, Illinois
1987
M.D. University of Cincinnati College of Medicine
Cincinnati, Ohio
July 1987-1988 Medical Internship
Union Memorial Hospital
Baltimore, Maryland
July
1988-1990 Internal Medicine Residency
Johns Hopkins Bayview Hospital
The Johns Hopkins Medical Institutions
Baltimore, Maryland
July
1991-1995 Post-Doctoral Fellowship
Division of Pulmonary & Critical Care
Medicine
The Johns Hopkins Hospital
Baltimore, Maryland
July
1992-1995 Post-Doctoral Fellowship
Center for Medical Genetics
Department of Pediatrics
The Johns Hopkins Hospital
Baltimore, Maryland
Professional
Experience:
July 2003- present Director of the pulmonary
and critical care medicine consultation service
for the liver transplant ICU
July 2002-Present Associate Clinical Professor
of Medicine
Division of Pulmonary & Critical Care
UCLA School of Medicine
July 1995-2002 Assistant Professor of Medicine
Division of Pulmonary & Critical Care
UCLA School of Medicine
West LA VA Medical Center
July
1990-1991 Instructor, Department of Medicine
The Johns Hopkins Hospital
Baltimore, Maryland
>>back to top
|
Representative
Publications:
Miller
PW, Hamosh A, Macek M Jr., Greenberger PA,
MacLean J, Walden SM, Slavin RG, Cutting GR.
CFTR mutations in allergic bronchopulmonary
aspergillosis. American Journal of Human Genetics
1996; 59:45-51.
Macek
M Jr., Mercier B, Mackova A, Miller PW, Hamosh
A, Ferec C, Cutting GR. Sensitivity of the
denaturing gradient gel electrophoresis technique
in detection of known mutations and novel
Asian mutations in the CFTR gene. Human Mutations
1997; 9:136-147.
Miller PW, Sharma S, Stolina M, Ken Chen,
Zhu LX, Paul RW, Dubinett SM. Dendritic cells
augment GM-CSF/herpes simplex virus thymidine
kinase gene therapy of lung cancer. Cancer
Gene Therapy 1998; 5:380-389.
Miller PW, Sharma S, Stolina M, Butterfield
L, Lin Y, Luo J, Dohadwala M, Batra RK, Economou
JS, Dubinett SM. Intratumoral administration
of adenoviral interleukin-7 gene-modified
dendritic cells augments specific antitumor
immunity and tumor eradication. Human Gene
Therapy 2000; 11: 53-65.
Eaton,T.E.,Weiner-Miller,
P., Garrett, J.E., Cutting,G.R. Cystic fibrosis
transmembrane conductance regulator gene mutations:
do they play a role in the aetiology of allergic
bronchopulmonary aspergillosis? Clin Exp Allergy
2002 May;32(5):756-61.
Dubinett
SM, Miller PW, Sharma S, Batra RK. Lung cancer
gene therapy.
Hematology -Oncology Clinics of North America.
1998 June; 12: 569-594.
Dubinett SM, Batra RK, Miller PW, Sharma S.
Tumor antigens in thoracic
malignancies.Am. J. of Resp. Cell and Molecular
Biol. 2000;22: 524-527.
>>back to top
, faculty
main
|
